Larvol Delta - A-Firstinhuman-Safety-Tolerability-and-Pharmacokinetics-Study-of-LXE408-in-Healthy-Subjects

LXE408 - Novartis

http://clinicaltrials.gov/ct2/show/NCT07809919

Sep 10, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next